In the present study, we initially screened out four differentially expressed subunits (LAMA3, LAMA4, LAMB3 and LAMC2) of the laminin gene family that were found to be associated with the clinical outcome of pancreas cancer patients in TCGA. This evidence concerns the gene LAMB2 and pancreatic neoplasm.